Search

At Memorial Sloan Kettering Cancer Center, we have now analyzed more than 50,000 samples in our prospective cohort with MSK-IMPACT™.

… Wednesday, February 24, 2021 At Memorial Sloan Kettering Cancer Center, we have now analyzed over 65,000 samples in our prospective cohort with MSK-IMPACT™ , our next-generation sequencing (NGS) platform, and are adding to that number every day. This is up 8000 from January this year, despite Covid-19

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10th class of Giants of Cancer Care® for his contributions in translational science.

… Monday, May 9, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10 th class of Giants of Cancer Care® for his contributions in translational science. The

Learn how immune cells in the lungs trigger invasive fungal cells to self-destruct. The discovery could produce therapies to prevent infection in cancer patients.

… Thursday, September 7, 2017 Summary Due to their weakened immune function, cancer patients who receive bone marrow transplants are at a high risk of infection from a common fungus called Aspergillus fumigatus . Researchers discovered that immune cells in the lungs of healthy people kill the fungal cells

Learn how Memorial Sloan Kettering Cancer Center kept caring for patients during the response to COVID-19, and how lessons learned during the pandemic are helping cancer care.

… Thursday, October 1, 2020 “It felt like watching a terrifying storm moving toward us in slow motion.” That is how Memorial Sloan Kettering lymphoma doctor Matthew Matasar describes watching the COVID-19 pandemic unfold. MSK doctors, researchers, and staff never wavered in their commitment to continue

Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms.

… Friday, December 8, 2017 Donna D’Alessio, MD Donna D’Alessio, MD Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms

Learn how a patient’s intestinal bacteria may influence the risk of cancers such as leukemia or lymphoma returning after bone marrow transplantation.

… Friday, March 17, 2017 Summary Researchers have known that intestinal bacteria, known as gut microbiota, can affect the risk of complications from bone marrow transplantation such as graft versus host disease. A new MSK study found an association between the presence of a bacterial group and a lower

Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.

… Thursday, May 9, 2013 Summary Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years. Christopher D. Lima , a structural biologist at Memorial Sloan Kettering,

A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.

… Thursday, July 29, 2021 Mesothelioma is a rare cancer that affects the lining surrounding organs, usually in the chest and abdomen. Treating this disease has been challenging because in most cases it is not possible to remove all the cancer with surgery. The FDA has approved only two new therapies since

When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat.

… Saturday, July 1, 2023 By Matt Tontonoz When Urvi Shah, MD , was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat. She thought, as a doctor who was training

MSK researchers identify mutations that convert nonthreatening thyroid tumors into aggressive cancers.

… Tuesday, August 8, 2017 Summary Most non-anaplastic thyroid cancers grow slowly and do not pose a threat. However, a small percentage become aggressive and spread quickly. Researchers have identified mutations that appear to turn these nonthreatening thyroid tumors into aggressive cancers. Highlights